Clinical

Dataset Information

Phase 1 study of human atrial natriuretic peptide during perioperative period for completely resected colorectal cancer


ABSTRACT: Interventions: hANP administration (0.025 maicrog/kg/min) is started at 2 hours before operation. hANP administration is continued for 3 days Primary outcome(s): Safety Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2641104 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR